Management of Uncomplicated Cystitis When Nitrofurantoin Is Unavailable

First‑Line Oral Therapies

• Trimethoprim‑sulfamethoxazole (TMP‑SMX) 160 / 800 mg twice daily for 3 days is recommended as the preferred empiric agent for adult women with uncomplicated cystitis when nitrofurantoin cannot be used, provided local E. coli resistance is < 20 % [1][2].
• In patients infected with TMP‑SMX‑susceptible uropathogens, clinical cure occurs in 90–100 % and bacteriologic eradication in 91–100 % [3][4].
• When the pathogen is resistant, clinical cure falls sharply (84 % vs 41 %), underscoring the need for local susceptibility data [3][5].

Alternative Oral Therapies

Fosfomycin Trometamol

• Single 3 g oral dose provides a regimen with minimal resistance development and low adverse‑event profile [1][6].
• Compared with standard short‑course agents, fosfomycin achieves a clinical cure rate of ~91 % (slightly lower than the 93–95 % seen with other agents) and a bacteriologic cure of 78–80 %, which is modestly inferior to nitrofurantoin’s 86 % [1][7]5.

Fluoroquinolones (Reserve Use)

• Ciprofloxacin 250 mg BID 3 days, Norfloxacin 400 mg BID 3 days, or Levofloxacin (appropriate dose) 3 days produce high bacteriologic cure rates of 89–92 % [3][8].
• Because of their potential for collateral damage and promotion of resistance, fluoroquinolones should be reserved for situations where other agents are unsuitable [1][8]6.

β‑Lactam Options (When No Other Agents Viable)

• β‑lactams are generally less effective and associated with more adverse events than TMP‑SMX, fosfomycin, or fluoroquinolones for uncomplicated cystitis [1][9].
• Amoxicillin or ampicillin alone should not be used empirically because of high resistance prevalence [1][9]6.

Decision Algorithm

• If < 20 % → prescribe TMP‑SMX 160/800 mg BID for 3 days [1][2].

• If ≥ 20 % → consider fosfomycin single dose or a fluoroquinolone (reserved) [1][2].

• Recent antibiotic exposure → avoid the same class 10.
• Pregnancy → TMP‑SMX contraindicated in the 1st and 3rd trimesters 11.
• Renal impairment → adjust choice/dose accordingly 10.

Special Considerations & Common Pitfalls

• Geographic variability of resistance: Do not assume TMP‑SMX susceptibility without local data; resistance rates can differ markedly [8][5].
• Duration of therapy: A 3‑day TMP‑SMX course is sufficient; longer courses provide no additional benefit [1][2].
• Fluoroquinolone stewardship: Use only when no other effective oral option exists, to preserve efficacy and limit ecological impact [1][6].
• Urine culture: Not required for typical uncomplicated cystitis, but should be obtained if symptoms persist or recur within 4 weeks 11.